Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Procter & Gamble

This article was originally published in The Tan Sheet

Executive Summary

Adds two non-drowsy caplet products to its DayQuil line -- Sinus Pressure and Congestion Relief, and Sinus Pressure and Pain Relief. Two new softgel products also will augment the Vicks Formula 44 line -- Non-drowsy Cold & Cough, and Cold, Flu & Cough. The four products will roll out in late July, P&G said. FSIs are scheduled in October and will include two dual-page ads, one featuring the line extensions. P&G reported that it expects to spend over $ 70 mil. across its cough/cold category in the coming year. In the future, the firm plans to launch a Vicks Children's NyQuil Headcold and Allergy product
Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

PS081639

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel